Scilex Reveals $20.3M Gross Proceeds from Warrant Exercise
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 24 2025
0mins
Should l Buy SCLX?
Warrant Exercise Agreement: Scilex Holding has entered into an agreement to exercise existing warrants for a total of 428,572 shares at $38.50 each and 475,824 shares at $22.72 each, expected to generate approximately $20.3 million in gross proceeds.
New Warrant Issuance: In exchange for the immediate cash exercise of the existing warrants, Scilex will issue a new unregistered warrant for 1,356,594 shares at an exercise price of $29.00, which will be exercisable immediately for five years.
Placement Agents: Rodman & Renshaw and StockBlock Securities are serving as the exclusive placement agents for this offering.
Use of Proceeds: The net proceeds from the offering will be utilized for working capital and general corporate purposes, with the closing expected around November 25, 2025, pending customary conditions.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SCLX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SCLX
About SCLX
Scilex Holding Company is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company’s commercial products include ZTlidoO (lidocaine topical system) 1.8% for the relief of neuropathic pain associated with postherpetic neuralgia (PHN); ELYXYB, a ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults; and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. In addition, it focuses on product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXAO), an epidural injections formulation to treat lumbosacral radicular pain, or sciatica; SP-103 (lidocaine topical system) 5.4%, a ZTlido formulation, for the treatment of acute pain; and SP-104 (4.5 mg, low-dose naltrexone hydrochloride delayed-release capsules) (SP-104) for fibromyalgia treatment.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
SCILEX HOLDING CO - SEC FILING REVEALS FUNDING FOR DATAVAULT'S QUANTUM-READY GPU INFRASTRUCTURE IN 100 U.S. CITIES
Company Overview: Cilex Holding Co. is focused on utilizing proceeds to fund a data vault for quantum-ready GPU infrastructure across 100 U.S. cities.
Investment Strategy: The initiative aims to enhance data processing capabilities and infrastructure readiness for quantum computing applications.
See More
Datavault AI Enters $120 Million Agreement with Scilex for Quantum-Ready Network Expansion
- Capital Injection: Datavault AI has signed a $120 million cash agreement with Scilex Holding Company to support the expansion of its quantum-ready GPU edge network, which is expected to significantly enhance the company's market competitiveness.
- Revenue Sharing Mechanism: Under the agreement, Scilex will receive a share of future revenues generated by Datavault AI's network, with structured revenue participation tiers capped at $1.2 billion, providing long-term revenue assurance for the company.
- Network Deployment Plan: Datavault AI plans to deploy a 'Quantum-Ready Edge Network' across 100 cities in the U.S., which will not only enhance the company's infrastructure capabilities but also meet future market demands for high-performance computing.
- Funding Combination Strategy: The company expects to combine this funding with other sources, including asset sales and receivable collections, targeting over $200 million in cash inflows, ensuring business growth without equity dilution.
See More
Scilex Announces Dividend of Dream Bowl Tokens to Shareholders
- Dividend Announcement: Scilex's Board approved the distribution of Dream Bowl I Meme Coin Tokens to shareholders, with a record date of April 30, 2026, allowing participants to receive five tokens per share held, which is expected to enhance shareholder value with approximately 81.4 million tokens distributed.
- Distribution Conditions: Participants must open a digital wallet with Datavault AI Inc. and sign an Opt-In Agreement to ensure they understand the token receipt process and potential changes, reflecting the company's commitment to transparency and compliance.
- Market Liquidity Expectations: Scilex intends to list the Dream Bowl Tokens on the Biconomy exchange, which is anticipated to enhance liquidity and broaden distribution among holders, potentially attracting more investor interest in the company's innovative products.
- Token Nature Clarification: The Dream Bowl Token is intended solely for personal, non-commercial use and does not confer any equity or financial rights, emphasizing its function as a digital collectible to mitigate investment risks and clarify the company's strategic direction.
See More
SCILEX HOLDING CO PLANS TO LAUNCH DREAM BOWL TOKENS ON BICONOMY EXCHANGE
- Company Announcement: Cilex Holding Co. intends to list Dream Bowl tokens on the Biconomy exchange.
- Market Impact: This move is expected to enhance the visibility and trading opportunities for Dream Bowl tokens in the cryptocurrency market.
See More
SCILEX HOLDING COMPANY DECLARES DIVIDEND OF DREAM BOWL I MEME COIN TOKENS FOR COMMON STOCKHOLDERS AND OTHER QUALIFIED EQUITY SECURITY HOLDERS, RECORD DATE SET FOR APRIL 30, 2026
- Dividend Announcement: Cilex Holding Company has announced a dividend of Dream Bowl Lime Meme Coin to holders of common stock and other eligible equity securities.
- Record Date: The record date for this dividend distribution is set for April 30, 2026.
See More
SCILEX HOLDING CO FACES COMPLAINT OVER UNAUTHORIZED SALE OF PLEDGED DVLT SHARES THROUGH BNY MELLON ACCOUNTS - SEC FILING
Complaint Filed: A complaint has been filed against CILEX Holding Co. alleging unauthorized sale of pledged DVLTS shares.
Involvement of SEC: The complaint has been submitted to the SEC, indicating regulatory scrutiny over the transaction.
See More
SCILEX HOLDING CO - SEC FILING REVEALS FUNDING FOR DATAVAULT'S QUANTUM-READY GPU INFRASTRUCTURE IN 100 U.S. CITIES
Company Overview: Cilex Holding Co. is focused on utilizing proceeds to fund a data vault for quantum-ready GPU infrastructure across 100 U.S. cities.
Investment Strategy: The initiative aims to enhance data processing capabilities and infrastructure readiness for quantum computing applications.
See More
Datavault AI Enters $120 Million Agreement with Scilex for Quantum-Ready Network Expansion
- Capital Injection: Datavault AI has signed a $120 million cash agreement with Scilex Holding Company to support the expansion of its quantum-ready GPU edge network, which is expected to significantly enhance the company's market competitiveness.
- Revenue Sharing Mechanism: Under the agreement, Scilex will receive a share of future revenues generated by Datavault AI's network, with structured revenue participation tiers capped at $1.2 billion, providing long-term revenue assurance for the company.
- Network Deployment Plan: Datavault AI plans to deploy a 'Quantum-Ready Edge Network' across 100 cities in the U.S., which will not only enhance the company's infrastructure capabilities but also meet future market demands for high-performance computing.
- Funding Combination Strategy: The company expects to combine this funding with other sources, including asset sales and receivable collections, targeting over $200 million in cash inflows, ensuring business growth without equity dilution.
See More
Scilex Announces Dividend of Dream Bowl Tokens to Shareholders
- Dividend Announcement: Scilex's Board approved the distribution of Dream Bowl I Meme Coin Tokens to shareholders, with a record date of April 30, 2026, allowing participants to receive five tokens per share held, which is expected to enhance shareholder value with approximately 81.4 million tokens distributed.
- Distribution Conditions: Participants must open a digital wallet with Datavault AI Inc. and sign an Opt-In Agreement to ensure they understand the token receipt process and potential changes, reflecting the company's commitment to transparency and compliance.
- Market Liquidity Expectations: Scilex intends to list the Dream Bowl Tokens on the Biconomy exchange, which is anticipated to enhance liquidity and broaden distribution among holders, potentially attracting more investor interest in the company's innovative products.
- Token Nature Clarification: The Dream Bowl Token is intended solely for personal, non-commercial use and does not confer any equity or financial rights, emphasizing its function as a digital collectible to mitigate investment risks and clarify the company's strategic direction.
See More
SCILEX HOLDING CO PLANS TO LAUNCH DREAM BOWL TOKENS ON BICONOMY EXCHANGE
- Company Announcement: Cilex Holding Co. intends to list Dream Bowl tokens on the Biconomy exchange.
- Market Impact: This move is expected to enhance the visibility and trading opportunities for Dream Bowl tokens in the cryptocurrency market.
See More
SCILEX HOLDING COMPANY DECLARES DIVIDEND OF DREAM BOWL I MEME COIN TOKENS FOR COMMON STOCKHOLDERS AND OTHER QUALIFIED EQUITY SECURITY HOLDERS, RECORD DATE SET FOR APRIL 30, 2026
- Dividend Announcement: Cilex Holding Company has announced a dividend of Dream Bowl Lime Meme Coin to holders of common stock and other eligible equity securities.
- Record Date: The record date for this dividend distribution is set for April 30, 2026.
See More
SCILEX HOLDING CO FACES COMPLAINT OVER UNAUTHORIZED SALE OF PLEDGED DVLT SHARES THROUGH BNY MELLON ACCOUNTS - SEC FILING
Complaint Filed: A complaint has been filed against CILEX Holding Co. alleging unauthorized sale of pledged DVLTS shares.
Involvement of SEC: The complaint has been submitted to the SEC, indicating regulatory scrutiny over the transaction.
See More
